ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 2,170,000 shares, a growth of 598.6% from the May 15th total of 310,600 shares. Currently, 10.4% of the shares of the stock are […]
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation. Risk and Volatility ReShape Lifesciences has a beta […]
ReShape Lifesciences Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 487,800 shares, a decline of 33.1% from the March 31st total of 729,300 shares. Based on an average daily volume of 520,900 shares, the short-interest ratio […]
22.02.2024 - FLEX Technology Designed to Enhance the Patient Experience Surgeon Training Underway for the Initial Launch of the Lap-Band 2.0 FLEX IRVINE, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) - ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led .